Harvard Pilgrim Health Care Institute launches new center for sepsis research

The Future of Sepsis Management: A Deep Dive into Emerging Trends Understanding the Omnipresent Challenge of Sepsis Sepsis remains a leading cause of mortality globally, affecting over 49 million individuals each year and causing 11 million deaths. Its unpredictability and the rapid timeframe required for effective intervention make it a critical area for medical advancement. … Read more

New insights into PTSD’s genetic architecture unveiled by Dr. Kerry Ressler

Unraveling the Genetic Code of PTSD: Emerging Trends in Genomic Research Recent advancements in genomic research offer a hopeful horizon for treating post-traumatic stress disorder (PTSD). Dr. Ressler’s monumental study, involving over a million participants, has identified around 100 genetic loci associated with PTSD, marking a pivotal leap in understanding its genetic makeup. This breakthrough, … Read more

Three new drug regimens offer hope for drug-resistant tuberculosis

The New Frontier in Tuberculosis Treatment The battle against tuberculosis (TB) has taken a significant leap forward with the development of new drug regimens targeting rifampin-resistant TB. A groundbreaking international clinical trial led by Harvard Medical School researchers, as part of the endTB project, has identified three effective and safe treatment combinations. These regimens herald … Read more